75 related articles for article (PubMed ID: 2191158)
1. [Treatment of four cases of B-cell lymphoma].
Kuroki Y; Tada S; Kitamura T; Kawana N; Ogata K; Idemori M; Inoue S
Nihon Hifuka Gakkai Zasshi; 1990 Jan; 100(1):71-84. PubMed ID: 2191158
[TBL] [Abstract][Full Text] [Related]
2. [T-cell lymphomas of the skin: a study of 7 cases excluding mycosis fungoides and adult T-cell leukemia/lymphoma].
Kuroki Y; Tateyama S; Kurokawa M; Amano M; Kobashi M; Kawana N; Narahara S; Tajiri A; Tada S; Okazaki M
Nihon Hifuka Gakkai Zasshi; 1989 Oct; 99(11):1173-82. PubMed ID: 2614987
[TBL] [Abstract][Full Text] [Related]
3. [T-cell lymphoma of the skin--clinicopathological relationships, therapy and survival].
Nagatani T; Kin S; Baba N; Miyamoto H; Nakajima H
Nihon Hifuka Gakkai Zasshi; 1989 Apr; 99(5):579-91. PubMed ID: 2585773
[TBL] [Abstract][Full Text] [Related]
4. Treatment results of tonsillar lymphoma: a 10-year experience.
Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
[TBL] [Abstract][Full Text] [Related]
5. [Cutaneous B-cell lymphoma treatment with rituximab: two cases].
Viguier M; Bachelez H; Brice P; Rivet J; Dubertret L
Ann Dermatol Venereol; 2002 Oct; 129(10 Pt 1):1152-5. PubMed ID: 12442128
[TBL] [Abstract][Full Text] [Related]
6. Nasal lymphoma. A clinicopathologic study with immunophenotypic and genotypic analysis.
Ferry JA; Sklar J; Zukerberg LR; Harris NL
Am J Surg Pathol; 1991 Mar; 15(3):268-79. PubMed ID: 1996731
[TBL] [Abstract][Full Text] [Related]
7. Secondary lymph node involvement from primary cutaneous large B-cell lymphoma of the leg: sentinel lymph nodectomy as a new strategy for staging circumscribed cutaneous lymphomas.
Starz H; Balda BR; Bachter D; Büchels H; Vogt H
Cancer; 1999 Jan; 85(1):199-207. PubMed ID: 9921993
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Dutch Cutaneous Lymphoma Working Group.
Vermeer MH; Geelen FA; van Haselen CW; van Voorst Vader PC; Geerts ML; van Vloten WA; Willemze R
Arch Dermatol; 1996 Nov; 132(11):1304-8. PubMed ID: 8915307
[TBL] [Abstract][Full Text] [Related]
9. [Primary breast lymphoma--a report of 27 cases with literature review].
Cao YB; Wang SS; Huang HQ; Xu GC; He YJ; Guan ZZ; Lin TY
Ai Zheng; 2007 Jan; 26(1):84-9. PubMed ID: 17222374
[TBL] [Abstract][Full Text] [Related]
10. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
11. [Primary centrocytic lymphoma of the skin: diagnosis, course and therapy (author's transl)].
Schultz-Ehrenburg U; Lämmer D
Dermatologica; 1981; 162(5):350-61. PubMed ID: 7250469
[TBL] [Abstract][Full Text] [Related]
12. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
[TBL] [Abstract][Full Text] [Related]
14. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.
Hausdorff J; Davis E; Long G; Hoppe R; van der Pas M; Lassman C; Kamel O; Jacobs C
Cancer J Sci Am; 1997; 3(5):303-11. PubMed ID: 9327155
[TBL] [Abstract][Full Text] [Related]
15. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
16. [Homogeneous clinical behavior of a group of cutaneous B-cell lymphomas].
de Misa RF; Sastre JL; Azaña JM; Escribano L; Suárez J; Bellas C
Sangre (Barc); 1995 Dec; 40(6):465-70. PubMed ID: 8850229
[TBL] [Abstract][Full Text] [Related]
17. Difference in prognosis between T- and B-cell lymphomas: clinical study at Shikoku Cancer Center Hospital.
Toki H; Okabe K; Kimura Y; Yumoto Y; Morita M; Ogushi I; Koike S; Takashima S; Sato G; Moriwaki S
Jpn J Clin Oncol; 1986 Mar; 16(1):41-8. PubMed ID: 3486301
[TBL] [Abstract][Full Text] [Related]
18. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
[TBL] [Abstract][Full Text] [Related]
20. [Relapse of diffuse large B cell lymphoma to CD20-negative multiple cutaneous tumors immediately after anti-CD20 monoclonal antibody (rituximab) therapy].
Iguchi T; Miyazawa K; Okabe S; Kawakubo K; Shimamoto T; Kuriyama Y; Ito Y; Kimura Y; Ohyashiki K; Serizawa H; Iwaya K; Mukai K
Rinsho Ketsueki; 2004 Oct; 45(10):1129-34. PubMed ID: 15553050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
